Hermann Steller

Title: Innovations of Hermann Steller in Apoptosis Regulation

Introduction

Hermann Steller is a prominent inventor based in New York, NY, known for his significant contributions to the field of apoptosis regulation. With a total of two patents, Steller's work focuses on developing compounds that can induce cell death, which is crucial in cancer treatment.

Latest Patents

Steller's latest patents include "Mitochondrial targeted stimulators of apoptosis - Pro-apoptotic compounds having a tripartite structure: A-L-Bare disclosed." These compounds consist of an IBM mimetic moiety (A), a linker (L), and a moiety that binds to a protein on the outer mitochondrial membrane (B). They are designed to induce cell apoptosis, thereby providing a potential therapeutic approach for cancer treatment. Another notable patent is "Peptides and methods for cell death regulation." This invention presents novel peptides, nucleic acids, compounds, compositions, and methods for regulating apoptosis. The regulation is mediated through IAPi-derived proteins and their peptide fragments, which can stimulate or suppress apoptosis.

Career Highlights

Throughout his career, Hermann Steller has worked with esteemed institutions such as The Rockefeller University and the Rappaport Family Institute for Research in the Medical Sciences. His research has significantly advanced the understanding of apoptosis and its implications in cancer therapy.

Collaborations

Steller has collaborated with notable colleagues, including Cristinel Sandu and Anshuman Kelkar, contributing to the advancement of research in apoptosis regulation.

Conclusion

Hermann Steller's innovative work in the field of apoptosis regulation has the potential to transform cancer treatment strategies. His patents reflect a deep understanding of cellular mechanisms and a commitment to advancing medical science.